Filterlex Medical successfully raised $3 million for Its Embolic Protection Device

An Israeli startup, Filterlex Medical which is developing a next-generation embolic protection device, made an announcement last week that they have completed a Series funding round raising a total of $3 million in the capital. The Yokneam-based firm has developed…

The lesser trickling of IPO in European Markets

European biotech companies engaged in discovery & development of drug raised an aggregate $3.172Bn in equity investment during the first six months of 2019, down 19 percent on the same period last year. Unless there is a significant pickup in…